Skip to main content

Calibre Scientific Acquires SciQuip, a UK Provider of Scientific Equipment, Supplies and Services

LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) — Calibre Scientific is pleased to announce the acquisition of SciQuip Ltd, a UK based provider of scientific equipment, laboratory supplies and services to customers in the research, university, hospital and biopharma sectors. SciQuip marks Calibre Scientific’s 12th acquisition in the British Isles, further expanding Calibre Scientific’s product and service offering in the region.

SciQuip is a leading laboratory supply company in the UK and offers a broad and diversified portfolio that includes product lines from centrifugation, incubation, ovens, freezers, freeze drying, liquid handling, to mission-critical laboratory equipment. In addition, SciQuip provides a variety of consumables together with comprehensive technical sales support, and repair and maintenance services to cater to its customers’ needs.

With this acquisition, Calibre Scientific bolsters its UK operations and further diversifies its existing product and service portfolio in the laboratory supplies market. “SciQuip is an exciting addition to the Calibre Scientific family as it brings over two decades of equipment experience and a number of complementary products and services to further bolster our Lab Products & Services division,” said Ben Travis, Chief Executive Officer of Calibre Scientific. “Together, with our growing life science and diagnostic solutions, equipment offering and global distribution platform, we are excited to continue to expand our range of capabilities serving laboratories worldwide.”

“SciQuip has always strived to provide the highest quality equipment, supplies and service to its customers in the most sustainable way,” said Matt Brooksbank, Managing Director of SciQuip. “We’re excited to join Calibre Scientific as there are clear synergies and shared values between the companies which can take SciQuip to new heights.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of life science and diagnostic companies that have an unrivaled ability to address its customers’ challenges in their respective markets. Our global reach extends to over 175 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.investor.calibrescientific.com, or contact press@calibrescientific.com. 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.